Page last updated: 2024-11-03

procarbazine and Aplasia Pure Red Cell

procarbazine has been researched along with Aplasia Pure Red Cell in 2 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alter, R1
Joshi, SS1
Verdirame, JD1
Weisenburger, DD1
Homeida, M1
Mukhtar, ED1
Daneshmend, T1
Omer, A1

Other Studies

2 other studies available for procarbazine and Aplasia Pure Red Cell

ArticleYear
Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin.
    Leukemia research, 1990, Volume: 14, Issue:3

    Topics: Antibodies, Anti-Idiotypic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow;

1990
Case report: multiagent chemotherapy of Hodgkin's disease associated with red cell aplasia, acquired ichthyosis and anhidrosis.
    East African medical journal, 1987, Volume: 64, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Hypohidrosis; Ichthyosis; M

1987